Faculty

Institution

Unit

Venue

Raymond Hohl

Pennsylvania State University

Affiliations

Penn State College of Medicine

Department of Medicine

Department of Pharmacology

Department of Medicine

Division of Hematology and Oncology

NoneRaymond Hohl is currently serving as a Medicine faculty at Pennsylvania State University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Raymond Hohl

Pennsylvania State University

You can click a keyword to filter the displayed items

pharmacology oncology medicinal research biochemistry medicine medicinal chemistry tumor biology hematology cancer research enzyme inhibition molecular biology cancer treatment vascular biology pharmacotherapy drug discovery oncogenes cancer cells cancer biology gene expression lipids leukemia anti-cancer agents cancer discovery redox biology clinical lipidology inhibitory activity tumor targeting hematological malignancies malignant blood disorders peptide science pharmacological research antioxidants cancer care protein science bone marrow transplantation pharmacokinetics clinical immunology transplantation medicine lipid chemistry pharmaceutical research stem cell transplantation cancer genetics pharmaceutical sciences cancer management lipid disorders primary production lipid science molecular evidence mevalonate pathway murine model key site experimental pharmacology catalyst activation molecular substrates direct observation trace elements synthetic chemistry meso level cellular immune responses protein expression novel therapies myeloid neoplasia renal dysfunction pharmacokinetic study acute myeloid leukemia quantitative determination ras-related proteins multiple myeloma cells cytosine arabinoside potential inhibitors biological activity oblimersen sodium advanced multiple myeloma osteoblast differentiation unfit patients first line treatment cancer institute clinical proteomics omics technologies mass spectrometry translational proteomics

Notable Scholarly Works

Notable Federal Grants

Collaborators

The Role of the Mevalonate Pathway in Post-Translational Modifications of Pd-L1. Journal of Pharmacology and Experimental Therapeutics (2024)

Ruoheng ZhangRaymond HohlJeffrey D. NeighborsEmily J. KoubekReid M. JoelJessie L. Reed

mevalonate pathwayprotein sciencebiochemistrypharmacologymembrane biologypost-translational modifications

Cytotoxic Effects of the Schweinfurthin Analog 5′-Methylschweinfurthin G in Malignant Plasma Cells. Pharmacology (2022)

Barbara ManfrediJeffrey D. NeighborsRaymond J. Hohl

lung cancerdrug resistancecytotoxic effectsinhibitory activitymalignant plasma cellsurologycellular therapytreatment effectsneurologycancer discoverytreatment optionsneuro-oncologyvascular biologybreast cancerspecific resistanceclinical lipidologyearly detectionprostate cancerenzyme inhibitionpathology

Low-Dose Total Body Irradiation Promotes T-Cells Donor Chimerism in Reduced-Intensity/Non-Myeloablative Allogeneic Stem Cell Transplant With Post-Transplant Cyclophosphamide. Leukemia Research (2022)

Neal ShahJoseph CioccioKevin RakszawskiHong ZhengMyles NickolichSeema NaikBaldeep WirkWitold RybkaChristopher EhmannBrook SilarCaitlin VajdicJoseph MierskiShouhao ZhouHiroko ShikeRobert GreinerValerie BrownRaymond HohlDavid ClaxtonShin MineishiKentaro MinagawaLeonard Tuanquin

organ transplantationmedicineradiation therapycancer biologyleukemiat-cells donor chimerismcell transplantationcancer researchoncologycancer carestem cell transplantationclinical transplantationradiation oncologyimmunologymedicinal researchhematologypost-transplant cyclophosphamidehematological malignanciesregenerative medicinetransplantation medicine

Post-Transplant Cyclophosphamide Alters Immune Signatures and Leads to Impaired T Cell Reconstitution in Allogeneic Hematopoietic Stem Cell Transplant. Journal of Hematology & Oncology (2022)

Chenchen ZhaoMatthew BartockBei JiaNeal ShahDavid F. ClaxtonBaldeep WirkKevin L. RakszawskiMyles S. NickolichSeema G. NaikWitold B. RybkaW Christopher C. EhmannRaymond J. HohlJessica ValentinMichelle Bernas-PetersonEmily M. GerberMichele ZimmermanJoseph A. MierskiShin MineishiHong Zheng

hepatologyhematologycancer immunotherapyimmune responsesmedicineoncologyadaptive immune systemclinical immunologyimmunologypharmacologycell transplantationstem cell transplantationcellular immune responsestransplantation medicine

Rnaseq Reveals Extensive Metabolic Disruptions in the Sensitive Sf-295 Cell Line Treated With Schweinfurthins. Scientific Reports (2022)

J. S. WeissenriederJ. D. WeissenkampenJ. L. ReedM. V. GreenC. ZhengJ. D. NeighborsD. J. LiuRaymond J. Hohl

developmental biologyscientific datatumor biologygeneticscell biologygenomicsmetabolic disruptionsmembrane biologyrna biologytreatment and preventiongenome biologygene expressiongene therapy

Therapeutic Potential of 5′-Methylschweinfurthin G in Merkel Cell Polyomavirus-Positive Merkel Cell Carcinoma. Viruses (2022)

Emily J. KoubekJillian S. WeissenriederLuz E. OrtizNnenna NwoguAlexander M. PhamJ. Dylan WeissenkampenJessie L. ReedJeffrey D. NeighborsRaymond J. HohlHyun Jin Kwun

virologymedicineantiviral researchcancer researchoncologycancer-associated virusmedical virologymedicinal researchvirus-host interactionsmedical mycologyviral oncologytherapeutic potentialcancer treatmentviral pathogenesiscervical cancervirus research

Abstract 316: Effect of Schweinfurthins on Malignant Plasma Cells. Cancer Research (2021)

Barbara ManfrediRaymond J. Hohl

urologytumor biologytherapeutic efficacyoncologycancer researchcancer biologycancer cellsoncogenesmalignant blood disordersimmunologypharmacologyvascular biologytherapeutic targetscancer treatmentmalignant diseasecarcinogenesismalignant plasma cellsmedicinal research

Antipsychotic Drugs Elicit Cytotoxicity in Glioblastoma Multiforme in a Calcium‐Dependent, Non‐D 2 Receptor‐Dependent, Manner. Pharmacology Research & Perspectives (2021)

Jillian S. WeissenriederJessie L. ReedGeorge‐Lucian MoldovanMartin T. JohnsonMohamed TrebakJeffrey D. NeighborsRichard B. MailmanRaymond J. Hohl

tumor biologyanti-cancer agentsmedicineoncologyneuropharmacologypharmacological researchclinical neuroscienceneuro-oncologyneuroscienceantipsychotic drugspharmacologybrain tumor researchcancer treatmenttumor targetingclinical pharmacologypharmacotherapyglioblastoma multiformemedicinal research

A Phase I Clinical Trial of Avelumab in Combination With Decitabine as First Line Treatment of Unfit Patients With Acute Myeloid Leukemia. American Journal of Hematology (2020)

Hong ZhengShin MineishiDavid ClaxtonJunjia ZhuChenchen ZhaoBei JiaW. Christopher EhmannWitold B. RybkaSeema NaikNatthapol SongdejJoseph J. DrabickRaymond J. Hohl

hematologymedicinepharmacologyfirst line treatmentunfit patientspharmacotherapyacute myeloid leukemiaclinical trials

Issue Information ‐ Editorial Board. Child Development Perspectives (2020)

Lisa GennetianCatherine Tamis-LemondaMichael FrankRick GilmorePamela ColeSuman VermaMarcel Van AkenCarol WorthmanPeng PengRogier KievitTracy RigginsJenny SaffranDavid MenendezIseli HernandezKarl Rosengren

information managementresearch ethicspublic relationsinformation policyissue managementeditorial independenceinformation sciencejournalism

1
2
3
4
5
14
10 / page

Raymond Hohl

Pennsylvania State University

Affiliations

Penn State College of Medicine

Department of Medicine

Department of Pharmacology

Department of Medicine

Division of Hematology and Oncology

NoneRaymond Hohl is currently serving as a Medicine faculty at Pennsylvania State University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Raymond Hohl

Pennsylvania State University

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

The Role of the Mevalonate Pathway in Post-Translational Modifications of Pd-L1. Journal of Pharmacology and Experimental Therapeutics (2024)

Ruoheng ZhangRaymond HohlJeffrey D. NeighborsEmily J. KoubekReid M. JoelJessie L. Reed

mevalonate pathwayprotein sciencebiochemistrypharmacologymembrane biologypost-translational modifications

Cytotoxic Effects of the Schweinfurthin Analog 5′-Methylschweinfurthin G in Malignant Plasma Cells. Pharmacology (2022)

Barbara ManfrediJeffrey D. NeighborsRaymond J. Hohl

Post-Transplant Cyclophosphamide Alters Immune Signatures and Leads to Impaired T Cell Reconstitution in Allogeneic Hematopoietic Stem Cell Transplant. Journal of Hematology & Oncology (2022)

Rnaseq Reveals Extensive Metabolic Disruptions in the Sensitive Sf-295 Cell Line Treated With Schweinfurthins. Scientific Reports (2022)

J. S. WeissenriederJ. D. WeissenkampenJ. L. ReedM. V. GreenC. ZhengJ. D. NeighborsD. J. LiuRaymond J. Hohl

developmental biologyscientific datatumor biologygeneticscell biologygenomicsmetabolic disruptionsmembrane biologyrna biologytreatment and preventiongenome biologygene expressiongene therapy

Therapeutic Potential of 5′-Methylschweinfurthin G in Merkel Cell Polyomavirus-Positive Merkel Cell Carcinoma. Viruses (2022)

Emily J. KoubekJillian S. WeissenriederLuz E. OrtizNnenna NwoguAlexander M. PhamJ. Dylan WeissenkampenJessie L. ReedJeffrey D. NeighborsRaymond J. HohlHyun Jin Kwun

Abstract 316: Effect of Schweinfurthins on Malignant Plasma Cells. Cancer Research (2021)

Barbara ManfrediRaymond J. Hohl

Antipsychotic Drugs Elicit Cytotoxicity in Glioblastoma Multiforme in a Calcium‐Dependent, Non‐D 2 Receptor‐Dependent, Manner. Pharmacology Research & Perspectives (2021)

Jillian S. WeissenriederJessie L. ReedGeorge‐Lucian MoldovanMartin T. JohnsonMohamed TrebakJeffrey D. NeighborsRichard B. MailmanRaymond J. Hohl

A Phase I Clinical Trial of Avelumab in Combination With Decitabine as First Line Treatment of Unfit Patients With Acute Myeloid Leukemia. American Journal of Hematology (2020)

Hong ZhengShin MineishiDavid ClaxtonJunjia ZhuChenchen ZhaoBei JiaW. Christopher EhmannWitold B. RybkaSeema NaikNatthapol SongdejJoseph J. DrabickRaymond J. Hohl

hematologymedicinepharmacologyfirst line treatmentunfit patientspharmacotherapyacute myeloid leukemiaclinical trials

Issue Information ‐ Editorial Board. Child Development Perspectives (2020)

information managementresearch ethicspublic relationsinformation policyissue managementeditorial independenceinformation sciencejournalism

1
2
3
4
5
14
10 / page

Similar Faculty Members

Shantu Amin

Institution

Pennsylvania State University

cancer letter

polycyclic aromatic hydrocarbon

Seongho Kim

Institution

Wayne State University

data analysis

personalized medicine

Said M. Sebti

Institution

Virginia Commonwealth University

receptor tyrosine kinase

molecular cancer

Sanjay Srivastava

Institution

University of Louisville

volatile organic compounds

free radical biology

Steven Grant

Institution

Virginia Commonwealth University

pathology

malignant blood disorder

Kit Lam

Institution

University of California, Davis

pharmacology

oncology

Salvatore Vincent Pizzo

Institution

Duke University

pharmacology

biochemistry

John Koomen

Institution

University of South Florida

proteomics

chemical cleavage mechanisms

Thomas Kipps

Institution

University of California, San Diego

pathology

hematological malignancies

Paul Insel

Institution

University of California, San Diego

gastrointestinal peptide hormone

gpcr expression

Similar Faculty Members

Shantu Amin

Institution

Pennsylvania State University

cancer letter

polycyclic aromatic hydrocarbon

Seongho Kim

Institution

Wayne State University

data analysis

personalized medicine

Said M. Sebti

Institution

Virginia Commonwealth University

receptor tyrosine kinase

molecular cancer

Sanjay Srivastava

Institution

University of Louisville

volatile organic compounds

free radical biology

Steven Grant

Institution

Virginia Commonwealth University

pathology

malignant blood disorder

Kit Lam

Institution

University of California, Davis

pharmacology

oncology

Salvatore Vincent Pizzo

Institution

Duke University

pharmacology

biochemistry

John Koomen

Institution

University of South Florida

proteomics

chemical cleavage mechanisms

Thomas Kipps

Institution

University of California, San Diego

pathology

hematological malignancies

Paul Insel

Institution

University of California, San Diego

gastrointestinal peptide hormone

gpcr expression